Isis Pharmaceuticals

USA

Isis Pharmaceuticals

2855 Gazelle Court

Stanley T Crooke, M.D., Ph.D. — Chairman of the Board & Chief Executive Officer
B Lynne Parshall, Esq. — Director & Chief Operating Officer
C Frank Bennett, Ph.D. — Senior Vice President, Research
Richard S Geary, Ph.D. — Senior Vice President, Development
Brett P. Monia, Ph.D. — Senior Vice President, Antisense Drug Discovery

Cardiology, Oncology, Endocrinology

Production

Diabetes, Virilia cancer, Hypertensive disease

ISIS

Stanley T. Crooke, M.D., Ph.D. — Chairman of the Board
Spencer R. Berthelsen, M.D.
Joseph Klein, III
Frederick T. Muto, Esq.*
B. Lynne Parshall, Esq.
John C. Reed, M.D., Ph.D.
Joseph H. Wender

7.4300

Cell Technologies, Nanotechnology, Devices, Services, Pharmaceuticals, Chemistry